Since accumulated evidences supporting a key role for MDM4 in the regulation of P53 tumor suppression function [14]–[17], it is biologically plausible to speculate that the decreased ESCC risk observed among MDM4 rs4245739 C allele carriers result from the increased tumor suppressor activity of P53. Here, TP53 is linked to neoplasm.